Clinical trial of lumbar fusion in combination with platelet rich plasma(PRP) and allograft.
Not Applicable
Recruiting
- Conditions
- lumbar stenosis
- Registration Number
- JPRN-UMIN000016058
- Lead Sponsor
- Graduate school of medicine chiba univresity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Not provided
Exclusion Criteria
1. severe systemic complication for example, heart failure,renal failure, liver failure, respiratory failure 2.anamnesis of AMI and cardiac hypofunction 3.complication of severe angina 4.severe renal function failure 5..severe lever function failure 6.respiratory functional failure 7.diabetes more than HbA1c9.0 8.psycological complication 9.pregnancy 10.hypersensitivity for thrombin 11.cardiac stimulation medication hypercalcemia 12.inadequate patients 13.disturbance of consciousness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie PRP and allograft in lumbar fusion for lumbar stenosis?
How does PRP combined with allograft compare to standard bone grafts in lumbar fusion outcomes?
Which biomarkers predict successful patient selection for PRP-allograft lumbar fusion therapy?
What are the potential adverse events associated with PRP-allograft lumbar fusion and how are they managed?
Are there alternative biologics or graft materials being studied for lumbar stenosis treatment efficacy?